RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding RAPT Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 98 | 96 | −2 |
| Shares | 34.1M | 34.8M | +713.1K (+2.1%) |
| Value | $636.7M | $577.8M | −$59.0M (−9.3%) |
New holders (5)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 276,749 | $4.60M | 0.00% |
| Point72 Asset Management, L.P. | 227,900 | $3.79M | 0.01% |
| Allianz Asset Management GmbH | 18,100 | $300.8K | 0.00% |
| ExodusPoint Capital Management, LP | 12,904 | $214.0K | 0.00% |
| Comerica Bank | 200 | $3.32K | 0.00% |
Sold out (7)
Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Balyasny Asset Management LLC | 144,605 | $2.70M |
| Renaissance Technologies LLC | 51,300 | $959.0K |
| Los Angeles Capital Management LLC | 28,748 | $537.6K |
| D. E. Shaw & Co., Inc. | 17,136 | $320.4K |
| Dynamic Technology Lab Private Ltd | 13,881 | $260.0K |
| Allspring Global Investments Holdings, LLC | 349 | $6.53K |
| Tucker Asset Management LLC | 100 | $1.87K |